NCT03823443View on ClinicalTrials.gov

COPD Exacerbation Blood and Urine Biomarkers Study

TerminatedOBSERVATIONAL

Enrollment

7

Participants

Timeline

Start Date

June 7, 2018

Primary Completion Date

August 22, 2019

Study Completion Date

January 8, 2021

Conditions

Chronic Obstructive Pulmonary DiseaseAcute Exacerbation CopdAlpha-1 Anti-trypsin Deficiency

Trial Locations (1)

10032

Columbia University Medical Center, New York

Sponsors

Collaborators (1)

Alpha-1 Foundation

All Listed Sponsors

collaborator

Alpha-1 Foundation

OTHER

lead

Columbia University

OTHER

NCT03823443 - COPD Exacerbation Blood and Urine Biomarkers Study | Biotech Hunter | Biotech Hunter